MedTrace Logo

Elmex Gel Efficacy in Preventing White Spot Lesions

NCT00268138 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 314

Last updated 2009-02-18

No results posted yet for this study

Summary

the objective of this phase IV study: to establish the efficacy of elmex gel with a fluoride concentration of 1.25% compared with placebo by determining prevention of white spot lesions in patients wearing fixed orthodontic appliances.

Conditions

  • Dental Caries

Interventions

DRUG

elmex gel

elmex gel once a week

Sponsors & Collaborators

  • Gaba International AG

    collaborator INDUSTRY

  • Hadassah Medical Organization

    lead OTHER

Principal Investigators

  • Meir Redlich, DMD PhD · Hadassah Medical Center, Dept of Orthodontics

  • Paul George Jost-Brinkmann, Prof · Charite - Berlin, Dept of Orthodontics, Center of Dentistry

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
10 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2006-04-30
Primary Completion
2010-12-31
Completion
2010-12-31

Countries

  • Germany
  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00268138 on ClinicalTrials.gov